Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer

This study has been completed.
Information provided by (Responsible Party):
Samyang Biopharmaceuticals Corporation Identifier:
First received: April 3, 2009
Last updated: June 11, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)